SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs > OncoSec Medical Inc. (ONCS)

;)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Vulcan4 Member Profile
 
Followed By 80
Posts 4,000
Boards Moderated 0
Alias Born 10/24/13
160x600 placeholder
OncoSec Announces $7.1 Million Registered Direct Offering Priced At-the-Market "PR Newswire (US)" - 10/23/2017 9:00:00 AM
OncoSec Presents Positive Phase 2 Data for ImmunoPulse® IL-12 in Combination with Pembrolizumab Demonstrating a Best Overall... "PR Newswire (US)" - 10/19/2017 6:00:00 AM
OncoSec to Host Fourth Quarter and Year End Financial Results Conference Call on October 25, 2017 "PR Newswire (US)" - 10/13/2017 8:00:00 AM
OncoSec to Present Updated Clinical and Immune Biomarker Data from its Monotherapy and Combination Therapy Studies with Immun... "PR Newswire (US)" - 10/12/2017 8:00:00 AM
OncoSec Announces Acceptance of Late Breaking Abstract at Upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting ... "PR Newswire (US)" - 10/11/2017 5:03:00 PM
OncoSec Initiates Registration Directed Clinical Trial, KEYNOTE-695, of ImmunoPulse® IL-12 in Combination with Merck's KEYTR... "PR Newswire (US)" - 10/10/2017 8:00:00 AM
OncoSec Presents Clinical Overview of Comprehensive Immune Monitoring Data Demonstrating Conversion of "Cold" Tumors to "Hot"... "PR Newswire (US)" - 9/27/2017 8:00:00 AM
OncoSec to Present at the Cantor Fitzgerald Global Healthcare Conference "PR Newswire (US)" - 9/26/2017 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/11/2017 6:17:55 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/11/2017 6:16:43 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 6:05:52 AM
OncoSec Appoints Industry Leader Daniel J. O'Connor to its Board of Directors "PR Newswire (US)" - 9/7/2017 6:00:00 AM
OncoSec Announces Presentations at Upcoming Investment and Scientific Conferences "PR Newswire (US)" - 9/6/2017 2:44:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 6:19:52 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/5/2017 6:19:20 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/5/2017 6:06:51 AM
OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors "PR Newswire (US)" - 9/5/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/2/2017 5:18:25 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/2/2017 5:15:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/25/2017 5:27:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 7/25/2017 5:25:24 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 6/12/2017 4:55:11 PM
OncoSec Announces Technology Access Program Agreement with Jounce Therapeutics, Inc. "PR Newswire (US)" - 6/12/2017 6:01:00 AM
OncoSec Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Unresectable Metastatic Melanoma "PR Newswire (US)" - 6/8/2017 4:30:00 PM
OncoSec to Present at LD Micro Invitational "PR Newswire (US)" - 6/2/2017 6:01:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist